Verona Pharma PLC ADR (VRNA) — Net Asset Quality Index
Verona Pharma PLC ADR (VRNA) has a Net Asset Quality Index of 48.6% as of June 2025. This metric measures the proportion of total assets financed by shareholders' equity — total assets of $572.87 Million minus total liabilities of $294.60 Million yields net assets of $278.27 Million. A higher index indicates a stronger, lower-leverage balance sheet. Read VRNA total debt and obligations for a breakdown of total debt and financial obligations.
Quality Index
Net Assets
Total Assets
Total Liabilities
Verona Pharma PLC ADR Net Asset Quality Index Over Time (2005–2024)
This chart shows how Verona Pharma PLC ADR's Net Asset Quality Index has evolved across 20 annual periods from 2005 to 2024. As of June 2025, the index stands at 48.6%, representing net assets of $278.27 Million against total assets of $572.87 Million USD. For live market cap and overall valuation, see market cap of Verona Pharma PLC ADR.
Annual Net Asset Quality Index for Verona Pharma PLC ADR (2005–2024)
The table below presents the year-by-year Net Asset Quality Index for Verona Pharma PLC ADR from 2005 to 2024, covering 20 annual filings. Each row shows total assets, total liabilities, net assets, the quality index percentage, and the change in percentage points compared to the prior year. Check strategic asset allocation of Verona Pharma PLC ADR to assess the company's strategic physical and investment asset allocation.
| Year | Quality Index | Net Assets (USD) | Total Assets | Total Liabilities | Change (pp) |
|---|---|---|---|---|---|
| 2024 | 43.1% | $204.56 Million | $474.24 Million | $269.68 Million | ▼ -37.8 pp |
| 2023 | 80.9% | $249.28 Million | $308.12 Million | $58.84 Million | ▼ -7.9 pp |
| 2022 | 88.8% | $230.47 Million | $259.47 Million | $29.00 Million | ▲ +9.5 pp |
| 2021 | 79.3% | $148.00 Million | $186.59 Million | $38.58 Million | ▼ -11.2 pp |
| 2020 | 90.5% | $184.85 Million | $204.21 Million | $19.35 Million | ▲ +15.5 pp |
| 2019 | 75.0% | $44.40 Million | $59.18 Million | $14.78 Million | ▼ -9.7 pp |
| 2018 | 84.7% | $79.86 Million | $94.23 Million | $14.37 Million | ▼ -4.5 pp |
| 2017 | 89.2% | $107.95 Million | $120.96 Million | $13.00 Million | ▲ +14.5 pp |
| 2016 | 74.7% | $42.53 Million | $56.93 Million | $14.40 Million | ▼ -0.8 pp |
| 2015 | 75.5% | $8.28 Million | $10.96 Million | $2.69 Million | ▼ -20.5 pp |
| 2014 | 96.0% | $19.62 Million | $20.43 Million | $816.08K | ▲ +15.1 pp |
| 2013 | 80.9% | $3.41 Million | $4.22 Million | $806.89K | ▼ -12.0 pp |
| 2012 | 92.9% | $4.21 Million | $4.53 Million | $322.11K | ▼ -3.4 pp |
| 2011 | 96.3% | $6.29 Million | $6.53 Million | $242.21K | ▲ +1.9 pp |
| 2010 | 94.4% | $5.33 Million | $5.64 Million | $317.94K | ▲ +0.4 pp |
| 2009 | 94.0% | $7.25 Million | $7.71 Million | $464.08K | ▼ -4.0 pp |
| 2008 | 97.9% | $5.85 Million | $5.97 Million | $123.01K | ▲ +3.1 pp |
| 2007 | 94.8% | $5.73 Million | $6.04 Million | $311.35K | ▼ -3.5 pp |
| 2006 | 98.3% | $7.64 Million | $7.77 Million | $129.31K | ▼ -0.5 pp |
| 2005 | 98.8% | $1.68 Million | $1.71 Million | $20.65K | — |